Strategic Priorities | ACS GCI Pharmaceutical Roundtable
Inform and Influence the Research Agenda
To monitor and identify new research opportunities with implications for more efficient process development and production.
To influence the technical agendas of federal/international funding agencies by defining needs and advocating investment in specific areas of green chemistry and engineering innovation.
To encourage external funding support for research in academic and government laboratories that will have direct value to the pharmaceutical industry.
Tools for Innovation
To identify, design, and provide tools available to member companies to promote green chemistry and engineering innovation within the industry. To provide a centralized resource for accumulating alternatives, sharing tools, maintaining the toolbox, and minimizing duplication of effort.
To educate and influence today's and tomorrow's pharmaceutical leaders on the business value and scientific merit of green chemistry and engineering and its application in the pharmaceutical industry.
To provide green chemistry and engineering expertise to pharmaceutical corporations worldwide by utilizing the ACS GCI network of international affiliates and researchers and by sharing best practices among our members.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Bristol-Myers Squibb
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Merck & Co., Inc
- Pfizer, Inc.
- ACS Green Chemistry Institute®